Douglas J. Swirsky
Director · Cellectar Biosciences, Inc.
- 2025
- Jul 9, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas J. Swirsky files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James V. Caruso - $25K in CLRB purchases and sales in the last 12 months
- Jarrod Longcor - $25K in CLRB purchases and sales in the last 12 months
- John Neis - $732 in CLRB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas J. Swirsky?
Douglas J. Swirsky is a corporate insider, tracked as Director of Cellectar Biosciences, Inc. (CLRB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Douglas J. Swirsky last file a Form 4?
The most recent primary Form 4 on record is dated 9 July 2026, one of 3 filings going back to 2025.
Has Douglas J. Swirsky been buying or selling stock?
Recorded transactions: 1 open-market purchase ($64K) and 1 open-market sale ($8K) across all tracked filings.
